Application of BAROS’ questionnaire in obese patients undergoing bariatric surgery with 2 years of evolution

Abstract

BACKGROUND
-In recent decades, the high prevalence of obesity in the general population has brought serious concerns in terms of public health. Contrarily to conventional treatment involving dieting and physical exercising, often ineffective in generating long term results, bariatric opera­tions have been an effective method for sustained weight loss in morbidly obese individuals. The Bariatric Analysis and Reporting Outcome System (BAROS) is an objective and recognized system in the overall evaluation of results after bariatric surgery.

OBJECTIVE
To investigate results concerning a casuistic of morbidly obese patients undergoing bariatric surgery over a 2-year follow-up in terms of weight loss, related medical conditions, safety and changes in quality of life.

METHODS
A total of 120 obese (17 male and 103 female) patients, who underwent bariatric surgery, were assessed and investigated using the BAROS system after a 2- year follow-up.

RESULTS
Patients obtained a mean excess weight loss of 74.6 (±15.9) % and mean body mass index reduction of 15.6 (±4.4) Kg/m². Pre-surgical comorbidities were present in 71 (59%) subjects and they were totally (86%) or partially (14%) resolved. Complications resulting specifically from the surgical procedure were observed in 4.2% of cases (two bowel obstructions requiring re-operation, and three stomal stenosis treated with endoscopic dilation). Sixteen subjects (13% of total number of patients) presented minor clinical complications managed through outpatient care. The final scores for the BAROS questionnaire showcased excellent to good results in 99% of cases (excellent 44%, very good 38%, good 23%, acceptable 1%).

CONCLUSION
According to the BAROS questionnaire, bariatric surgery is a safe and effective method for managing obesity and associated clinical comorbidities, allowing for satisfactory results after a 2-year follow-up. Future studies should address other clinical and psychosocial variables that impact outcome as well as allow for longer follow-ups.

Full text

ORIGINAL ARTICLE
60 • Arq Gastroenterol • 20 17 . v.54 No.1 Jan/Mar
INTRODUCTION
In recent decades, the high prevalence of obesity in the general
population has brought serious concerns in terms of public health.
Overweight and obesity have signicantly increased morbidity
and mortality around the world due to its associated medical
conditions
(12)
.
According to World Health Organization’s projections, the
situation is even more dramatic because it is estimated that by
2030, approximately two third of the world’s population would be
overweight or obese (2.2/3.3 billion)
(11)
.
According to the IBGE (Brazilian Institute of Geography and
Statistics), from 2006 to 2013 the prevalence of obesity (BMI>30)
in adults increased from 11.8% to 17.5%, and for the rst time men
reached approximately the same obesity rate of women.
Consequently, the increased incidence of overweight and obe-
sity in the Brazilian general population is overloading the public
health system (SUS – Unied Public Health System), requiring
treatment of these conditions and associated diseases
(13)
.
The burden of obesity is related to serious health consequences
associated to obesity, including type-2 diabetes, cardiovascular
disease, musculoskeletal disorders and certain types of cancers.
Application of BAROS’ questionnaire in obese
patients undergoing bariatric surgery with
2 years of evolution
Caetano de QUEIROZ1, José Afonso SALLET2, Pedro Gabriel Melo DE BARROS E SILVA1,
Luzia da Gloria Pereira de Sousa QUEIROZ1, Jélis Arenas PIMENTEL2 and Paulo Clemente SALLET2
Received 11/4/2016
Accepted 10/8/2016
ABSTRACT – Background – In recent decades, the high prevalence of obesity in the general population has brought serious concerns in terms of public
health. Contrarily to conventional treatment involving dieting and physical exercising, often ineffective in generating long term results, bariatric opera-
tions have been an effective method for sustained weight loss in morbidly obese individuals. The Bariatric Analysis and Reporting Outcome System
(BAROS) is an objective and recognized system in the overall evaluation of results after bariatric surgery. Objective – To investigate results concerning
a casuistic of morbidly obese patients undergoing bariatric surgery over a 2-year follow-up in terms of weight loss, related medical conditions, safety
and changes in quality of life. Methods – A total of 120 obese (17 male and 103 female) patients, who underwent bariatric surgery, were assessed and
investigated using the BAROS system after a 2- year follow-up. Results – Patients obtained a mean excess weight loss of 74.6 (±15.9) % and mean
body mass index reduction of 15.6 (±4.4) Kg/m2. Pre-surgical comorbidities were present in 71 (59%) subjects and they were totally (86%) or partially
(14%) resolved. Complications resulting specically from the surgical procedure were observed in 4.2% of cases (two bowel obstructions requiring
re-operation, and three stomal stenosis treated with endoscopic dilation). Sixteen subjects (13% of total number of patients) presented minor clinical
complications managed through outpatient care. The nal scores for the BAROS questionnaire showcased excellent to good results in 99% of cases
(excellent 44%, very good 38%, good 23%, acceptable 1%). Conclusion – According to the BAROS questionnaire, bariatric surgery is a safe and effective
method for managing obesity and associated clinical comorbidities, allowing for satisfactory results after a 2-year follow-up. Future studies should
address other clinical and psychosocial variables that impact outcome as well as allow for longer follow-ups.
HEADINGS – Morbid obesity. Bariatric surgery. Body weight. Quality of life.
Declared conflict of interest of all authors: none
Disclosure of funding: no funding received
1 Hospital Vitória, São Paulo, SP, Brasil; 2 Instituto de Medicina Sallet, São Paulo, SP, Brasil.
Correspondence: Jélis Arenas Pimentel. Rua Gomes de Carvalho, 1507. Bairro Vila Olímpia – CEP: 04547-005 – São Paulo, SP, Brasil. E-mail: jelisarenas@gmail.com
Some of these conditions are directly related to the principal causes
of death, such as heart disease and stroke
(16)
. Several other condi-
tions associated to obesity can lead to a reduced life expectancy
and poor quality of life, such as obstructive sleep apnea, infertility,
obstetric complications and psychiatric comorbidities
(6)
.
Contrarily to conventional treatment involving dieting and
physical exercising, often ineffective in generating long term re-
sults
(10)
, bariatric operations have been an effective method for
sustained weight loss in morbidly obese individuals
(2,7,9)
.
The Roux-en-Y gastric bypass (RYGBP) limits caloric intake
and also reduces calorie absorption. Other mechanisms such as
alterations in postprandial circulating levels of gut hormones may
also contribute to the weight loss observed after these bariatric
operations
(4)
.
However, weight loss is not the only criteria for successful
outcome following bariatric surgery, since the improvement in
comorbidities and changing health-related quality of life are also
very important criteria of outcome, especially for the patient’s
perspective.
The bariatric analysis and reporting outcome system (BAROS)
is an objective and recognized system in the overall evaluation of
results after bariatric surgery
(17,18)
.
AG-2016-35
dx.doi.org/10.1590/S0004-2803.2017v54n1-12

Queiroz C, Sallet JA, de Barros e Silva PGM, Queiroz LGPS, Pimentel JA, Sallet. PC.
Application of BAROS’ questionnaire in obese patients undergoing bariatric surgery with 2 years of evolution
Arq Gastroenterol • 20 17 . v.54 No.1 Jan/Mar • 61
The BAROS combines the Moorehead- Ardelt QoL question-
naire, which incorporates questions about self-esteem and activity
levels as items impacting QoL, with other data relevant to evalu-
ation of bariatric surgery outcomes, including the percentage of
excess weight loss. (%EWL), improvement in co-morbid conditions,
and complications, Therefore, it produces a valid and reliable as-
sessment of the QoL outcomes after weight loss surgery. Several
studies have used the BAROS, allowing fairly consistent compara-
tive analysis between various research centers
(1,3,14)
.
The main objectives of the present study are to report results
concerning a casuistic of morbidly obese patients undergoing
RYGB after a period of 2 years. They were analysed in terms of
weight loss, improvement of obesity related medical conditions,
and quantitative changes in health-related quality of life (QoL),
discussing our results comparatively to the current literature docu-
menting results regarding these outcome variables.
METHODS
This is a retrospective, descriptive study with a quantitative
approach, carried out with a sample of 120 medical records of
patients undergoing bariatric surgery, laparoscopic Roux-en-Y
gastric bypass (RYGB), at a center of excellence certied by Surgical
Review Corporation (SRC) and Brazilian Society of Bariatric And
Metabolic Surgery (SBCBM) in 2012 for the realization of such
surgery in the state São Paulo (Hospital and Maternity Vitoria).
The patient’s charts were selected and data were collected through
the institution database, using the following inclusion criteria:
patients who underwent RYGB between the months of March to
June 2011 aged 20 to 50 years.
For the scope of comparison, we conducted a search for articles
on the platform PubMed with the keywords: bariatric surgery,
RYGB and BAROS.
The calculation of %EWL (percent of excess weight loss) was
based on the Mean Ideal Weight Women and Men According to
Height
(15)
.
Data were collected through the institution database, in order
to obtain information concerning the changes occurred on the fol-
lowing items: loss of excess weight, evolution of comorbidities and
surgical or clinical complications. The ve aspects of quality of life
(self-esteem, willingness to physical activity, sociability, willingness
to work and sex life) were assessed by telephone calls, according
to the BAROS items. This evaluation method using the BAROS
instrument allowed us to classify the patients into ve groups (poor,
acceptable, good, very good or excellent) based on a score table.
Surgical procedures were performed by a team of largely ex-
perienced surgeons, according to standard techniques described in
routine Roux-en-Y gastric by-pass guidelines (RYGB)
(19)
.
Diagnostic criteria and assessment of clinical co-morbidities,
and parameters considered in the analysis of outcome were based
on specications proposed by Oria and Moorehead
(17,18)
. The cur-
rent analysis followed the ethical aspects described in the Declara-
tion of Helsinki and the Document of the Americas. The protocol
and all other applicable documents were approved by the local
institutional review board.
Statistics
Statistics were computed using IBM SPSS statistical package,
version 20. In the descriptive statistics, continuous variables were
presented as means and standard deviation and categorical vari-
ables as frequencies and percentages. Kolmogorov-Smirnov tests
were used to test normality of distributions among continuous vari-
ables: age, BMI reduction and %EWL showed normal distributions.
BAROS scores related to %EWL (P<0.001), QoL (P=0.002) and
BAROS total scores (P=0.04) showed non-normal distributions.
ANOVA and Mann-Whitney tests were used according to the
normality of distributions. A maximum limit of signicance of 5%
was dened for chance of type I error (P<0.05) in two-tailed tests.
RESULTS
Clinical demographical data and weight loss results:
Results concerning clinical data, baseline and end-point
variables in 120 patients
(103 women and 17 men) are showed in Table 1.
Patients showed highly signicant reductions in weight and
BMI along the 2-year follow-up period (mean days after sur-
gery=794 (±33) days). Overall, mean percent excess weight loss
was 74.6 (±15.9) and BMI reduction was 15.6 (±4.4) Kg/m
2
. Women
showed%EWL higher than men (F=10.7; P=0.001). However, with
reference to BMI reduction, women showed just a non-signicant
trend to higher reduction comparatively to men (F=2.7; P=0.102).
TABLE 1. Clinical, baseline and 2-year follow-up variables in 120 patients submitted to RYGB
Gender Age
(years)
Baseline
BMI
Baseline
Weight
Excess
Weight Final Weight Final BMI BMI
Reduction
%Excess
Weight Loss
Hospital
(days)
Male (n=17) 36.2 (±7.6) 46.1 (±6.4) 152.3 (±32.7) 81.5 (±31.0) 101.4 (±21.4) 32.2 (±5.9) 13.9 (±5.9) 63.4 (±15.5) 3.4 (±1.0)
Female (n=103) 36.2 (±7.0) 44.2 (±4.3) 120.5 (±16.2) 61.2 (±14.0) 74.7 (±12.5) 28.3 (±4.3) 15.8 (±4.1) 76.5 (±15.3) 3.4 (±1.8)
Total (n=120) 36.2 (±7.1) 44.5 (±4.7) 125.0 (±22.2) 64.0 (±18.7) 78.5 (±16.8) 28.9 (±4.8) 15.6 (±4.4) 74.6 (±15.9) 3.4 (±1.7)
Statistics
Men:Women
F=0.001;
P=0.970
F=2.48;
P=0.118
F=39.6;
P<0.001
F=20.01;
P<0.001
F=52.93;
P<0.001
F=10.19;
P=0.002
F=2.71
P=0.102
F=10.68
P=0.001
Statistics
BaseLine:Final
T=39.7;
df=119;
P<0.000
T=38.4;
df=119;
P<0.000
RYGB: Roux-en-Y gastric bypass

Queiroz C, Sallet JA, de Barros e Silva PGM, Queiroz LGPS, Pimentel JA, Sallet. PC.
Application of BAROS’ questionnaire in obese patients undergoing bariatric surgery with 2 years of evolution
62 • Arq Gastroenterol • 20 17 . v.54 No.1 Jan/Mar
BAROS results
Results of row scores obtained from the 120 subjects using the
BAROS scale are presented on Table 2. Referencing the total score
of the BAROS scale, women presented better results comparatively
to men (Mann-Whitney P=0.005). Table 2 shows us that this effect
was mainly.
TABLE 2. BAROS scores in 120 obese subjects after a 2-year follow-up following RYGB
Gender BAROS %EWL BAROS QoL BAROS Control
Comorbidities
BAROS
Complications Total BAROS
Men (n=17) 2.12 (±0.70) 2.08 (±0.75) 1.24 (±1.39) -0.13 (±0.33) 5.3 (±1.5)
Women (n=103) 2.52 (±0.57) 2.36 (±0.68) 1.77 (±1.44) -0.13 (±0.30) 6.6 (±1.7)
Total (n=120) 2.47 (±0.61) 2.32 (±0.69) 1.69 (±1.44) -0.13 (±0.30) 6.4 (±1.7)
Mann-Whitney U test Mann-Whitney
(P=0.018)
Mann-Whitney
(P=0.140)
Mann-Whitney
(P=0.110)
Mann-Whitney
(P=0.586)
Mann-Whitney
(P=0.005)
RYGB: Roux-en-Y gastric bypass. EWL: excess weight loss. QoL: quality of life.
TABLE 3. Surgical and clinical complications according to BAROS
criteria in 120 morbidly obese patients who underwent RYGB after a
2-year follow-up.
Complications N (%)
SURGICAL
Major (-1.0)
Early
Late
Bowel obstruction (*)
---
2 (1.7%)
---
Minor (-0.2)
Early
Late
---
Stomal stenosis
---
3 (2.5%)
CLINICAL
Major (-1.0)
Early
Late
Pulmonary embolism
---
1 (0.8%)
---
Minor (-0.2)
Early
Late
Deep venous thrombosis
Dysfagia
Urinary tract infection
Persistent nausea and vomiting
Anemia
Renal lithiasis
Metabolic deciency
Depression
2 (1.7%)
1 (0.8%)
1 (0.8%)
1 (0.8%)
7 (5.8%)
1 (0.8%)
2 (1.7%)
1 (0.8%)
Incidental
Cholelithiasis*
(-1.0)
Late After bariatric surgery
(2 year- follow up)
9 (7.5%)
RYGB: Roux-en-Y gastric bypass. * Choletithiase is not considered as a complication of
bariatric surgery
Associated with the highest scores in BAROS %EWL observed
in women (mean=2.52 ±0.57) as compared to men (mean=2.12
±0.70) (P=0.018), followed by a tendency to relatively better satis-
faction in women concerning items of quality of life (although not
signicant, P=0.14). However, there were no signicant differences
between gender regarding partial BAROS scores involving QoL,
control of comorbidities, or clinical/surgical complications.
Regarding pre-surgical comorbidities described as categorical
data, within male patients (n=17), 9 (53%) showed no comorbidi-
ties, 3 (18%) cardiovascular, 2 (12%) metabolic syndromes, and 1
(6%) pulmonary/lung conditions. Only two male subjects showed
association of 2 comorbidities (cardiovascular and metabolic,
12%). In the group of women (n=103), there were 40 (39%) cases
without comorbidities, 23 (22%) cases with cardiovascular, 6 (6%)
with osteoarticular, 4 (4%) with metabolic, 2 (2%) with gastroin-
testinal, and 1 (1%) with pulmonary clinically relevant conditions.
Sixteen women showed association between cardiovascular and
metabolic disorders (15.5%) and 4 (4%) between cardiovascular and
osteoarticular disorders. Two women showed association between
trhee or more comorbidities.
From the eight men presenting pre-surgical comorbidities,
there was full resolution in ve (62.5%) cases and partial resolu-
tion in three(37.5%) cases. From the 63 women with pre- surgical
comorbidities, 56 (89%) cases showed complete resolution and
seven (11%) cases partial resolution of comorbidities. Overall,
from the 71 (59%) subjects suffering from pre- surgical conditions,
complete (61 [86%] cases) or partial resolution (10 [14%] cases) was
observed in all subjects.
The analysis of surgical and/or clinical complications showed
that in 92 subjects (13 [76.5%] men and 89 [74.2%] women) there
were no complications at all. Concerning the complications strictly
arising from the surgery, reoperation due to bowel obstruction was
needed in two patients (1.7% of total casuistic) and there were three
(2.5%) cases of stomal stenosis, solved by endoscopic dilation.
Therefore, complications specically resulting from the surgical
procedure were observed in 4.2% of cases.
Along the 2-year follow-up, nine (7.5%) patients showed in-
cidental cholelitiasis and needed cholecystectomy. Sixteen (13%
of total casuistic) subjects presented minor clinical complications
managed by means of outpatient treatment (1 man and 15 women).
On the other hand, one patient (0.8% of total casuistic) suffered
major clinical complication requiring hospital admission due to pul-
monary embolism as early clinical complication. All complications
were solved with specic clinical measures or surgical procedures
during hospitalizations shorter than 7 days, with no mortality.
Complications are listed in Table 3.

Queiroz C, Sallet JA, de Barros e Silva PGM, Queiroz LGPS, Pimentel JA, Sallet. PC.
Application of BAROS’ questionnaire in obese patients undergoing bariatric surgery with 2 years of evolution
Arq Gastroenterol • 20 17 . v.54 No.1 Jan/Mar • 63
Thus, total scores of the BAROS scale allowed good (28 cases
[23%]), very good (38 [32%] cases) or excellent results (53 [44%]
cases) in 99% of the total sample (119 cases). (Table 4)
needed cholecystectomy. Sixteen (13% of total casuistic) subjects
presented minor clinical complications managed by means of
outpatient six treatment (one man and 15 women). On the other
hand, one (0.8% of total casuistic) patient suffered a major clini-
cal complication requiring hospital admission due to pulmonary
embolism. All complications were treated clinically or surgically,
with admissions to hospital lasting less than 7 days. No deaths
were documented.
Regarding total scores obtained with the BAROS questionnaire,
results were considered excellent by 44% of patients, very good by
32%, good by 23%, and acceptable by one (0.8%) patient. Overall,
the majority of patients (99%) presented with scores varying from
good to excellent. This result seems to be consistent with other
studies, as e.g., the study of Suter and colleagues
(21)
. That particular
study involved 379 patients undergoing RYGB in Switzerland, and
it found that more than 95% of patients had a good to excellent
5-year overall result according to the BAROS score.
Changes in QoL
Several surgical teams have been using the BAROS system in
the follow-up of bariatric patients in order to analyse quality of
life variables. In our study, in spite of gender, subjects scored a
mean of 2.32 (SD=0.69) in the items of QoL. According to the
BAROS scalar ranking for QoL evaluation, most of patients rated
their condition as improved or much improved. Again, the mean
score related to QoL in our sample was similar to those presented
in the latest literature
(21)
.
Finally, it is wise to point out some of the limitations of our
study: Putative (?) characteristics of patients that may impact re-
sults concerning weight loss and QoL, such as ethnicity, fat mass,
physical activity, level of education, and psychiatric state were not
documented. Other than that, the casuistic of male subjects was
relatively small compared to women, and a longer period of follow-up
would be advisable in order to assess the stability of results.
CONCLUSION
The present study, based on the follow-up of 120 patients 2 years
after underwent to RYGB, conrms previous results concerning
efcacy and safety of bariatric surgery in the control of obesity and
related conditions. The mortality rate was zero. Patients showed
mean %EWL of 75% and total or partial control of clinical condi-
tions in all 71 cases suffering from pre- surgical co-morbidities. This
surgical procedure proved to be safe, with 4.2% percent of cases
presenting with complications specically related to the surgical
procedure. Sixteen (13% of the total casuistic) subjects experienced
clinical complications requiring clinical outpatients treatment
(9.1% of the total patients) or in some cases including hospital
admission (6.9% of the total patients). As reported by a number
of studies, using the BAROS system allows us to identify good
to excellent results concerning items of quality of life and overall
satisfaction. We have also found that both male gender and age can
be associanted with poor results as far as weight reduction. Based
on our experience and medical literature, it is recommended that
future studies also investigate other important variables impacting
the outcome of bariatric interventions, such as medical (e.g., fat
mass), psychosocial (e.g., education, income, depression, compul-
sive eating)
(8,20)
, ethnic, and lifestyle (e.g., inactivity, overeating), in
order to better identify inuential variables and risk factors over
longer periods of follow-up.
TABLE 4. Results concerning total score of BAROS showed in cate-
gorical data of 120 subjects submitted to RYGB at the end of a 2-year
follow-up period
Total BAROS
Categorical
data
Acceptable Good Very good Excellent
Man
(n=17) 09
(7.5%)
3
(2.5%)
5
(4.2%)
Women
(n=103)
1
(0.8%)
19
(15.8%)
35
(29.2%)
48
(40%)
Total
(n=120)
1
(0.8%)
28
(23.3%)
38
(31.7%)
53
(44.2%)
RYGB: Roux-en-Y gastric bypass. X2=9.8; P=0.020.
DISCUSSION
Weight loss
After a period of 2 years, patients showed mean %EWL of
74.6 (±15.9) and BMI reduction of 15.6 (±4.4). These results are
similar to those found in literature. Indeed, a recent metanalysis
has reported mean %EWL of 74.4% and BMI reduction of 14.5
in randomized controlled studies of patients underwent gastric
bypass after 2-years of follow-up
(5)
.
Overall, literature reports that male gender and age are nega-
tively associated with weight loss after bariatric procedures
(3)
.
Our study showed that women drop a higher percentage of
excess weight when compared to men. There was also a trend to
the same effect with reference to BMI reduction. However, since
those differences in BMI reduction showed just a non-signicant
trend to higher reduction of weight in women (F=2.7; P=0.102)
as well as higher %EWL That seems to be partially resulting
from the lower baseline mean excess weight of women compara-
tively to men. On the other hand, controlling for pre-surgical
BMI, we have found trends to negative correlations between age
and %EWL (R= -0.160; P=0.083) and age and BMI reduction
(R= -0.165; P=0.073).
Outcome variables according to BAROS scores
We have used the Bariatric Analysis and Reporting Outcome
System (BAROS) in order to access variables impacting outcome
results of bariatric surgery. Improvement of co-morbid conditions
associated with obesity is one of the most important variables
considered in the success of bariatric treatment. In the present
sample of subjects, from 71 cases with one or more co-morbidites
associated to obesity, there were complete remission in 61 (86%)
cases and partial resolution in 10 (14%) cases.
With reference to complications strictly arising from the
surgery (4.2% of cases), reoperation was needed in two patients
(1.7% of total casuistic) due to bowel obstruction and three in
cases due to stomal stenoses (treated through endoscopic dila-
tion). Along the follow-up, nine patients showed cholelitiasis and

Queiroz C, Sallet JA, de Barros e Silva PGM, Queiroz LGPS, Pimentel JA, Sallet. PC.
Application of BAROS’ questionnaire in obese patients undergoing bariatric surgery with 2 years of evolution
64 • Arq Gastroenterol • 20 17 . v.54 No.1 Jan/Mar
ACKNOWLEDGEMENTS
We acknowledge the Vitória Hospital Staff specially Dr.
Marcio Arruda, Dr. Pedro Roberto Fausto, Dr. Vinicius Fer-
reira da Rocha and Dr. Nelcy do Amaral for logistic support and
Dra. Flávia Carvalho Silveira for the text revision and scientic
contributions.
Authors’ contributions
Queiroz C: research idealizer, data collector, data processor.
Sallet JA: literature review, statistic reviewer article reviewer. deBar-
ros e Silva PGM: article production, data processor. Queiroz LGPS:
data collector, article production. Pimentel JA: corresponding
author, literature review, article production. Sallet. PC: translator,
article production, technical reviewer.
REFERENCES
1. Al Harakeh AB, Larson CJ, Mathiason MA, Kallies KJ, Kothari SN. BAROS
results in 700 patients after laparoscopic Roux-en-Y gastric bypass with sub-
set analysis of age, gender, and initial body mass index. Surg Obes Relat Dis.
2011;7:94-8.
2. Anderson T, Backer OG, Stockholn KH. Randomized trial of gastroplasty
compared with diet alone in morbid obesity. N Engl J Med. 1984;310:352-6.
3. Ballantyne GH. Measuring outcomes following bariatric surgery: weight loss
parameters, improvement in co-morbid conditions, change in quality of life and
patient satisfaction. Obes Surg. 2003;13:954-64.
4. Batterman RL, Cowley MA, Small CJ, et al. Gut hormone PYY3-36 physiolog-
ically inhibits food intake. Nature. 2002;418:650-4.
5. Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness
and risks of bariatric surgery: an updated systematic review and meta-analysis,
2003-2012. JAMA Surg. 2014;149:275-87.
6. Colquitt JL, Pickett K, Loveman E, Frampton GK. Surgery for weight loss in
adults (Review). Cochrane Database of Systematic Reviews 2014, Issue 8. Art.
No.: CD003641. DOI: 10.1002/14651858.CD003641.pub4.
7. Deitel M, Shikora SA. The development of surgical treatment of morbid obesity.
J Am Coll Nutr. 2002;21:365-71.
8. Gordon PC, Sallet JA, Sallet PC. The impact of temperament and character
inventory personality traits on long-term outcome of Roux-en-Y gastric bypass.
Obes Surg. 2014;24:1647-55.
9. Greenstein RJ, Rabner JG, Taler Y. Bariatric surgery vs conventional dieting in
the morbidly obese. Obes Surg. 1994;4:16-23.
10. Juhaeri SJ, Chambless, Taylor HA, et al. Weight change among self-reported
dieters and non-dieters in white and African American men and women. Eur J
Epidemiol. 2001;17:917-23.
11. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005
and projections to 2030. Int J Obes (Lond). 2008;32:1431-7.
Queiroz C, Sallet JA, de Barros e Silva PGM, Queiroz LGPS, Pimentel JA, Sallet. PC. Aplicação do questionário BAROS em pacientes obesos submetidos
à cirurgia bariátrica com 2 anos de evolução. Arq Gastroenterol. 2017,54(1):60-4.
RESUMO – Contexto – Nas últimas décadas, a alta prevalência de obesidade na população geral trouxe grandes preocupações para a saúde pública.
Contrariamente ao tratamento convencional envolvendo dieta e atividade física, quase sempre inefetivo em gerar resultados a longo prazo, a cirurgia
bariátrica vem se mostrando um método efetivo de perda de peso mantida em indivíduos com obesidade mórbida. O Bariatric Analysis and Reporting
Outcome System (BAROS) é um sistema reconhecido e objetivo para a avaliação global de resultados depois de cirurgia bariátrica. Objetivo–In-
vestigar os resultados referentes à casuística de pacientes obesos mórbidos submetidos à cirurgia bariátrica em um período de 2 anos em termos de
perda de peso, condições clínicas relacionadas, segurança e qualidade de vida. Métodos – Um total de 120 pacientes obesos (17 masculinos e 103
femininos) admitidos consecutivamente durante período de 4 meses para cirurgia bariátrica foram avaliados e investigados usando o sistema BAROS
após 2 anos de evolução. Resultados – Os pacientes apresentaram redução média percentual de excesso de peso de 74,6 (±15,9) % e redução média
de índice de massa corporal de 15,6 (±4,4) Kg/m2. Comorbidades pré-cirúrgicas estavam presentes em 71 (59%) pacientes e em todos eles foram total
(86%) ou parcialmente (14%) resolvidas. Complicações resultantes especicamente do procedimento cirúrgico foram observadas em 4,2% dos casos
(duas obstruções intestinais exigindo reoperação e três estenoses anastomóticas resolvidas com dilatação endoscópica). Dezesseis (13%) pacientes
apresentaram complicações clínicas menores resolvidas com manejo clínico ambulatorial. Os escores totais do BAROS classicaram os resultados
como excelente até bom em 99% dos casos (44% excelente, 38% muito bom e 23% bom) e aceitável em 1% dos casos. Conclusão – De acordo com o
questionário BAROS, a cirurgia bariátrica se mostrou segura e efetiva no controle da obesidade e de comorbidades clínicas associadas, permitindo
satisfação geral dos pacientes após 2 anos de seguimento. Estudos futuros deverão também investigar outras variáveis clínicas e psicossociais de possível
impacto na evolução e por períodos de seguimento mais longos.
DESCRITORES – Obesidade mórbida. Cirurgia bariátrica. Peso corporal. Qualidade de vida.
12. Mancini MC. Bariatric surgery – An update for the endocrinologist. Arq Bras
Endocrinol Metab. 2014;58:875-88.
13. Marcelino LF, Patricio ZM. A complexidade da obesidade e o processo de viver
após a cirurgia bariátrica: uma questão de saúde coletiva. Ciênc. Saúde Coletiva
[Internet]. 2011, vol.16, n.12, pp. 4767-4776. ISSN 1413-8123. http://dx.doi.
org/10.1590/S1413-81232011001300025.
14. Marchesini JB, Nicareta JR. Comparative study of ve different surgical tech-
niques for the treatment of morbid obesity using BAROS. Arq Bras Cir Dig.
2014;27(Suppl. 1):17-20.
15. Metropolitan height and weight tables. Stat Bul Metrop Live Found. 1983, v.64,
n.1, p.3-9.
16. Oliveira MRM, Fortes RC. [Effects of Reducing Gastric Intestinal Bypass with
Roux-Y on severe obesityand metabolic syndrome: a literature review] Comun
Ciênc Saúde. 2013;24:267-80.
17. Oria HE, Moorehead MK. Bariatric analysis and reporting outcome system.
Obes Surg. 1998;8:487–99.
18. Oria HE, Moorehead MK. Updated Bariatric Analysis and Reporting Outcome
System (BAROS). Surgery for Obesity and Related Diseases. 2009(5):60-6.
19. Pizani CE, Sallet JA, Sallet PC. Laparoscopic surgery of the small bowel.
In: Eldo E Frezza; Michel Gagner; Michel K W Li (Org.). International
principles of laparoscopic surgery. Woodburry: Ciné-Med Publishing. 2009;
p. 547-56.
20. Sallet PC, Sallet JA, Dixon JB, Collis E, Pisani CE, Levy A, Bonaldi FL, Cordás
TA. Eating behavior as a prognostic factor for weight loss after gastric bypass.
Obes Surg. 2007;17:445-51.
21. Suter M, DonadiniA, Romy S, Demartines N, Giusti V. Laparoscopic Roux-
En-Y Gastric Bypass. Signicant Long-Term Weight Loss, Improvement of
Obesity-Related Comorbidities and Quality of Life. Ann Surg. 2011;254:
267-73.